MISSION Therapeutics offers a platform for the development of small molecule drugs that selectively target deubiquitylating enzymes (DUBs).

Biotechnology

Health Care

Life Sciences

Therapeutics

MISSION Therapeutics

MISSION Therapeutics' headquarters in Cambridge, United Kingdom

Anker Lundemose

Suhail Nurbhai

Sarah Fritchley

Craig Richardson

Gabriella Camboni

Philip Cohen

Carole Nuechterlein

Colin Goddard

Patrick Maxwell

Jacob Corn

Patrick Chinnery

Gabriella Gamboni

Steve Jackson

Denis Patrick

Jonathan Hepple

Samir M. Parikh

James B. Summers

Graziano Seghezzi

Matthew Foy

The Advisory Team at MISSION Therapeutics provides strategic guidance and expert advice on the development of small molecule drugs targeting deubiquitylating enzymes (DUBs). Composed of industry veterans and scientific leaders, the team supports decision-making processes and helps steer the company's scientific and business strategies.

Advisory Team

The Directors team at MISSION Therapeutics is responsible for overseeing strategic direction, operational efficiency, and financial planning. This team ensures alignment across key areas such as project management, pharmaceutical development, and translational biomarkers to drive the development of innovative small molecule drugs targeting deubiquitylating enzymes (DUBs).

Directors

The Scientific and Clinical Research Team at MISSION Therapeutics is dedicated to the discovery and preclinical development of small molecule drugs targeting deubiquitylating enzymes (DUBs). This team conducts in vitro and in vivo pharmacology studies, evaluates drug safety and efficacy, and supports clinical trial readiness by integrating data from pharmacometrics and non-clinical safety assessments.

Scientific and Clinical Research Team

The Leadership Team at MISSION Therapeutics drives the strategic direction and operational excellence of the company, focusing on the innovative development of small molecule drugs targeting deubiquitylating enzymes. Comprised of key executives, including the CEO, CFO, and Chief Scientific Officer, this team collaborates to align scientific research, business strategy, and financial management, ensuring the advancement of therapeutic solutions that address critical medical needs.

Leadership Team

The Clinical and Scientific Team at MISSION Therapeutics is responsible for driving the development and clinical validation of small molecule drugs targeting deubiquitylating enzymes (DUBs). The team combines expertise in medical strategy, scientific research, clinical trial management, and bioinformatics to advance therapeutic candidates from discovery through regulatory approval.

Clinical and Scientific Team

MISSION Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Directors

Scientific and Clinical Research Team

Leadership Team

Clinical and Scientific Team

Offices

MISSION Therapeutics

Org chart

Board & advisors

Teams

Advisory Team

Directors

Scientific and Clinical Research Team

Leadership Team

Clinical and Scientific Team

Offices

Related companies